The Hydroxyanthracene Derivatives Symposium featured cutting-edge contributions about analysis, quality, safety and efficacy of this interesting phytochemical substance class. It also provided a platform for dialogue and scientific knowledge transfer for participants from industry, regulatory bodies, academia or education.

Flyer «Analysis, Safety, Quality and Efficacy in Herbal Medicinal Products - April 11th»

Phytopharmacy and Natural Products Research Group

The Second Symposium of Industrial Biocatalysis hosted speakers from Switzerland and abroad who talked about current challenges in the field.

Flyer «First Network Meeting Innovation in Biocatalysis - June 6th» (PDF 302,2 KB)

Flyer «Second Symposium of Industrial Biocatalysis - June 7th» (PDF 442,2 KB)

What will the future bring? Our students will design them. That's why, together with our partners from industry and research, we are already developing the latest technologies that map the production processes of tomorrow. Amongst others, we present techniques such as flow chemistry, microreactor technology and 3D printing for personalized implants and entire fabrics.

Flyer: detailed information and agenda (PDF 205,2 KB)

Biocatalysis enables the sustainable production of chiral and highly functionalized compounds for the chemical and pharmaceutical industry. The Competence Centre of Biocatalysis at the ZHAW promotes biocatalysis as a complementary method to classic organic synthesis. It aims to help bridge the gap between academic laboratories and the production plant.

Flyer: detailed information and agenda (PDF 463,8 KB)

Competence Center for Biocatalysis (CCBIO)

A Precision Medicine initiative in the USA, announced by President Obama in January 2015, is designed to promote wider use of patient-specific medical care. The aim is to deliver new and more effective treatments for diseases. But what is going on in this ambitious, challenging field in Switzerland and in Europe? 

Flyer: detailed information and agenda (PDF 428,1 KB)

Download speeches

Current and future trends in personalized medicine, (PDF 3,5 MB)Dr. Bruce Jordan, Roche Diagnostics

International Ltd Challenges of personalized health for clinical medicine (PDF 2,5 MB), Prof. Dr. Peter Meier-Abt, Swiss Academy of Medical Sciences, Basel 

Implementing research in personalized medicine (PDF 1,8 MB), Prof. Dr. Niko Beerenwinkel, ETH Zurich, Competence Center Personalized Medicine

Osteosarcoma: Current perspectives and future development (PDF 7,3 MB), Prof. Dr. Bruno Fuchs, Sarcoma Center UZH, University Hospital Balgrist 

Gene therapy in ophthalmology – the TargetAMD project (PDF 2,1 MB), Dr. Martina Kropp, University Hospital Geneva 

TEDD information (PDF 1,7 MB), Prof. Dr. Ursula Graf-Hausner, Zurich University of Applied

Sciences Exhibition slam (PDF 3,2 MB)

In der Verwendung von Holz als Baustein für chemische Produkte und zur Herstellung neuartiger Verbundstoffe liegt ein grosses Potenzial für die Ablösung der global noch stark erdölbasierten Materialwirtschaft. Der 6. Chemietag der ZHAW widmet sich den vielfältigen wissenschaftlichen und unternehmerischen Herausforderungen, die sich in der Forschung und Entwicklung innovativer holzbasierter Materialien aktuell stellen.

Flyer: Informationen und Programm (PDF 463,1 KB)

Download Referate

Aktivitäten am Institut für Chemie und Biologische Chemie, (PDF 2,2 MB) Prof. Dr. Christian Hinderling, Institutsleiter ICBC, ZHAW, Wädenswil

Innovations-Suchfelder für holzbasierte Materialien, (PDF 2,2 MB)Dr. Willi Schwotzer, Psetta GmbH, Neuenkirch

Polymere Nanoverbundswerkstoffe mit Zellulose Nanofasern (PDF 6,1 MB), Prof. Dr. Christoph Weder, Adolphe Merkle Institut, Marly

Holz als Chemierohstoff: Extraktion von Tanninen aus Rinden heimischer Nadelhölzer (PDF 1,4 MB), Dr. Frédéric Pichelin, Berner Fachhochschule, Biel

Wasserfeste, dimensionsstabile LVL aus Buchenholz (PDF 2,2 MB), Prof. Dr. Holger Militz, Georg-August-Universität, Göttingen

Bio-inspirierte Materialien aus Holz (PDF 1,8 MB), Prof. Dr. Ingo Bugert, ETH Zürich

Im Fokus dieser Veranstaltung stehen aktuelle didaktische Herausforderungen im Unterricht an Berufs- und Fachhochschulen. Diese tragen zum Erfolg des dualen Bildungssystems in der Schweiz bei. Zudem hat die Bologna-Reform zu einer Internationalisierung beigetragen, die ein länderübergreifendes Qualitätsmanagement nötig erscheinen lässt (Eurobachelor).

Flyer: Informationen und Programm (PDF 195,7 KB)

Medienmitteilung (PDF 52,5 KB)

Download Referate

SwitchCast Videos der Vorträge

Sunlight is the most abundant and reliable source of energy available to humanity. In order to provide a truly widespread primary energy source, solar energy must be harvested, converted, and stored in a cost-effective manner. These three key steps require scientific and technological breakthroughs. Chemistry contributes to this development by creating new materials for capturing sunlight, converting light to electricity, enabling light-driven reactions, or increasing the long-term stability of solar cells.

Flyer: detailed information and agenda (PDF 525,0 KB)

Download speeches (slides)

Photovoltaics in Switzerland - the cycle of research, technology, industry and markets (PDF 3,4 MB), Dr. Stefan Nowak, Programme Manager, Swiss Photovoltaic Research Programme, Swiss Federal Office of Energy

Modeling and simulation of photoelectrochemical cells (PDF 2,5 MB), Dr. Matthias Schmid, ZHAW

New trends in organic materials based solar cells (PDF 3,9 MB), Prof. Dr. Frank Nüesch, EMPA

Running chemical reactions at ultra-high temperatures for solar energy storage - potential and challenges (PDF 10,2 MB), Dr. Ivo Alxneit, Solar Technology Laboratory, PSI

The pharmaceutical industry is of global economic importance. As a central component, drug development is a complex process that requires interdisciplinary research and development. Only the effective collaboration of different scientific disciplines enables the development of new medicines for the benefit of patients.

Flyer: information and programme (PDF 2,2 MB)

Download speeches (slides)

Drug discovery in the academic setting (PDF 6,0 MB) (Rainer Riedl, ZHAW)

VIBRANT a European Project for Betacell Imaging and Quantification (PDF 5,4 MB) (Theo Schotten, CAN GmbH)

Blocking AMRE - Chemistry and Biochemistry at a Nasty Enzyme (PDF 1,3 MB) (Andreas Natsch, Fridtof Schröder, Givaudan Schweiz AG)

VirtualToxLab TM - In silico prediction of the toxic potential of drugs and chemicals (PDF 3,0 MB) (Angelo Vedani, Department of Pharmaceutical Sciences, University of Basel)

Discovery of the Novel, Orally Active S1P Receptor Agonist ACT-128800 (Ponesimod) (PDF 3,7 MB) (Martin Bolli, Actelion Pharmaceuticals Ltd)